BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7031112)

  • 1. Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever.
    Norman PS; Lichtenstein LM; Marsh DG
    J Allergy Clin Immunol; 1981 Dec; 68(6):460-70. PubMed ID: 7031112
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled evaluations of repository therapy in ragweed hay fever.
    Norman PS; Winkenwerder WL; D'Lugoff BC; Tignall J
    J Allergy; 1967 Feb; 39(2):82-92. PubMed ID: 5340238
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new desensitization agent in the treatment of ragweed-induced seasonal allergic rhinitis (hay fever) in children: MRTA (modified ragweed tyrosine adsorbate)].
    Weisnagel J
    Union Med Can; 1979 Jun; 108(6):685-90. PubMed ID: 116408
    [No Abstract]   [Full Text] [Related]  

  • 5. A statistical review of double-blind studies on ragweed hay fever injection therapy.
    Miller A
    Ann Allergy; 1968 Jul; 26(7):339-47. PubMed ID: 4873806
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of immunotherapy on immunoglobulin E and immunoglobulin G antibodies to ragweed antigens: a six-year prospective study.
    Gleich GJ; Zimmermann EM; Henderson LL; Yunginger JW
    J Allergy Clin Immunol; 1982 Oct; 70(4):261-71. PubMed ID: 6811645
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever.
    Lichtenstein LM; Norman PS; Winkenwerder WL
    Am J Med; 1968 Apr; 44(4):514-24. PubMed ID: 4171086
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies.
    Lichtenstein LM; Norman PS; Winkenwerder WL
    Ann Intern Med; 1971 Nov; 75(5):663-71. PubMed ID: 4107763
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical and immunologic efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever.
    Meriney DK; Kothari H; Chinoy P; Grieco MH
    Ann Allergy; 1986 Jan; 56(1):34-8. PubMed ID: 2418713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
    Bousquet J; Hejjaoui A; Soussana M; Michel FB
    J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymerized allergens.
    Patterson R; Suszko IM
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and immunologic evaluation of glutaraldehyde-modified tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trial.
    Metzger WJ; Dorminey HC; Richerson HB; Weiler JM; Donnelly A; Moran D
    J Allergy Clin Immunol; 1981 Dec; 68(6):442-8. PubMed ID: 6796618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and standardization of polymerized ragweed extracts by chromatography, radioimmunoassay inhibition, and end point cutaneous titration.
    Grammer LC; Silvestri L; Suszko IM; Shaughnessy MA; Patterson R
    J Allergy Clin Immunol; 1983 Aug; 72(2):160-7. PubMed ID: 6886254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P; Holdich T; Fischer von Weikersthal-Drachenberg KJ; Huber B
    J Allergy Clin Immunol; 2014 Jan; 133(1):121-9.e1-2. PubMed ID: 23870670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic changes during specific treatment of the atopic state. 3. The immunologic response in the course of hyposensitization of hay fever patients with aqueous and alum - pyridine allergens.
    Zavázal V; Stajner A
    Acta Allergol; 1970 Apr; 25(1):18-24. PubMed ID: 5468237
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos.
    Norman PS; Winkenwerder WL; Lichtenstein LM
    J Allergy; 1968 Aug; 42(2):93-108. PubMed ID: 4873833
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disodium cromoglycate in ragweed-allergic rhinitis.
    Knight A; Underdown BJ; Demanuele F; Hargreave FE
    J Allergy Clin Immunol; 1976 Aug; 58(2):278-83. PubMed ID: 7585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.